Internal Medicine, Gastroenterology · Clackamas, OR
NPI
1215158704
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9900 SE Sunnyside Rd
Clackamas, OR, 97015
Phone (503) 571-8240
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$536K
713 prescriptions
Company payments, 2023
$225
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ben J Bryant prescribed most often to Medicare patients was Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 372 prescriptions and refills. In total Ben J Bryant wrote 713 Medicare prescriptions that cost $536K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-04.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 372 | 372 | 362 | $9,367 |
| Mesalamine Generic | 46 | 114 | 18 | $27K |
| Budesonide Dr Budesonide | 36 | 67 | 13 | $3,790 |
| Pantoprazole Sodium Generic | 25 | 75 | 11 | $407 |
| Azathioprine Generic | 24 | 46 | Under 11 | $800 |
| Stelara Ustekinumab | 23 | 33 | Under 11 | $391K |
| Balsalazide Disodium Generic | 14 | 30 | Under 11 | $3,247 |
| Nortriptyline Hcl Generic | 13 | 13 | Under 11 | $105 |
| Metronidazole Generic | 12 | 12 | Under 11 | $165 |
| Proctofoam-Hc Hydrocortisone/Pramoxine | 12 | 12 | Under 11 | $18K |
| Glydo Lidocaine Hcl | 12 | 12 | Under 11 | $12K |
| Creon Lipase/Protease/Amylase | 11 | 11 | Under 11 | $6,922 |
Brand drugs: - claims; generic drugs: 617 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Ben J Bryant $225 ($225 in general payments such as food, travel and fees) from 7 companies. The largest payer was Nestle Healthcare Nutrition Inc. with $61.01.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.